Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Disconnect between sputum neutrophils and other measures of airway inflammation in asthma

Joseph R. Arron, David F. Choy, Michel Laviolette, Steven G. Kelsen, Ammar Hatab, Richard Leigh, Neil C. Thomson, Eugene R. Bleecker, Ron Olivenstein, Pedro C. Avila, Nizar N. Jarjour, Mario Castro, Gail M. Gauvreau, James T. Good, Joel N. Kline, Adel Mansur, Irvin Mayers, Liam G. Heaney, Qutayba Hamid, Jeffrey M. Harris
European Respiratory Journal 2014 43: 627-629; DOI: 10.1183/09031936.00117013
Joseph R. Arron
1Genentech Research and Early Development, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David F. Choy
1Genentech Research and Early Development, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Laviolette
22IUCPQ, Université Laval, Quebec, QC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven G. Kelsen
3Dept of Medicine, Temple University School of Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ammar Hatab
4West Coast Clinical Trials LLC, Costa Mesa, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Leigh
5Faculty of Medicine, University of Calgary, Calgary, AB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil C. Thomson
66Institute of Infection, Immunity, and Inflammation, University of Glasgow, Glasgow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eugene R. Bleecker
7Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ron Olivenstein
8Montréal Chest Institute, Montreal, QC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro C. Avila
9Dept of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nizar N. Jarjour
10Dept of Medicine, University of Wisconsin-Madison, Madison, WI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Castro
11Dept of Medicine, Washington University School of Medicine, St Louis, MO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail M. Gauvreau
12Dept of Respirology, Faculty of Health Sciences, McMaster University, Hamilton ON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James T. Good
13Dept of Medicine, National Jewish Health, Denver, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel N. Kline
1414Dept of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adel Mansur
15Respiratory Dept, Birmingham Heartlands Hospital, Birmingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irvin Mayers
16Dept of Medicine, University of Alberta, Edmonton, AB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liam G. Heaney
17Centre for Infection and Immunity, Queens University Belfast, Belfast, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qutayba Hamid
1818Meakins-Christie Laboratories, McGill University, Montreal, QC, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey M. Harris
1Genentech Research and Early Development, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: harris.jeffrey@gene.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editor:

Asthma heterogeneity has been described by the nature and intensity of granulocytic infiltration into the airways [1, 2]. Sputum, endobronchial biopsies and bronchoalveolar lavage (BAL) sample different anatomical regions of the airways. Few studies have directly compared the inflammatory cell infiltrates in these regions within a large cohort of moderate–severe asthma patients using standard techniques.

In the BOBCAT (Bronchoscopic exploratory research study Of Biomarkers in Corticosteroid-refractory AsThma) study, we sampled multiple airway compartments concurrently, enabling us to evaluate relationships between granulocytic infiltrates within and between compartments in a large cohort of moderate–severe adult asthma patients. This prospective multicentre observational study was conducted in four visits over a 4–6 week period, as described previously [3].

The patients included had moderate–severe persistent asthma (forced expiratory volume in 1 s (FEV1) 40–80% predicted and Asthma Control Questionnaire (ACQ) [4] score >1.5) and, within the past 5 years, evidence of >12% post-bronchodilator reversibility or a provocative concentration of methacholine causing a 20% decline in FEV1 ≤8 mg·mL−1 despite high-dose inhaled corticosteroid (ICS) (≥1000 μg·day−1 fluticasone propionate equivalent) with or without long-acting β2-adrenergic agonist therapy. Key exclusion criteria included initiation or increase in systemic steroid use 30 days prior to screening, chronic or recent (within the past 30 days) use of immunosuppressive therapies, or other active lung disease. Patients had a prior established diagnosis of moderate–severe asthma for ≥6 months prior to screening while receiving a stable dose regimen (>6 weeks) of a high-dose ICS. Allowed concomitant medications included leukotriene receptor antagonists and oral corticosteroids.

78 patients with confirmed moderate–severe asthma were enrolled at 18 sites; 67 (86%) completed the study. All patients had persistently impaired lung function and uncontrolled symptoms despite high-dose ICS treatment of ≥1000 μg·day−1 fluticasone propionate equivalent. 11 (14%) patients did not complete the study, due to an adverse event (n=1), physician’s decision (n=5), subject’s decision (n=3) or the sponsor’s decision (n=2). One patient experienced increased bronchospasm following bronchoscopy, requiring additional observation and oral corticosteroid treatment prior to being discharged home from the final study visit.

We enumerated sputum, tissue and BAL eosinophils and neutrophils using standard techniques as described previously [5, 6]. Both granulocyte types spanned broad ranges and had a unimodal distribution in each compartment (fig. 1). The majority of nonsquamous cells in sputum from most subjects were neutrophils, while a much smaller percentage of sputum cells were eosinophils. The majority of BAL cells were macrophages (data not shown), with eosinophils and neutrophils comprising <10% of total BAL cells in most cases.

Figure 1–
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1–

Relationships between eosinophil and neutrophil levels in each airway compartment. a) Eosinophil and neutrophil counts in endobronchial biopsy tissue; median (interquartile range) neutrophils 31 (17–56) cells·mm−2 and eosinophils 23 (7–44) cells·mm−2. Percentages of nonsquamous cells in b) induced sputum; median (IQR) neutrophils 52 (37–71)% and eosinophils 5 (2–15)%; and c) bronchoalveolar lavage (BAL) fluid; median (IQR) neutrophils 2 (1–8)% and eosinophils 1 (0–3)%. rS: Spearman’s rank correlation.

Within each compartment, eosinophils and neutrophils were significantly intercorrelated. However, these correlations were positive in biopsy tissue and BAL but negative in sputum (fig. 1). The correlation within any single compartment was greatest in biopsy tissue (Spearman’s rank correlation (rS)=0.68, p<0.0001). Across compartments, sputum eosinophils were significantly, albeit weakly, positively correlated with both biopsy tissue eosinophils (rS=0.36, p<0.05) and BAL eosinophils (rS=0.33, p<0.05), while neutrophils were not intercorrelated across any compartments. Sputum neutrophils were negatively correlated with tissue eosinophils (rS= -0.37, p<0.01) and BAL eosinophils (rS= -0.34, p<0.05). These findings show generally positive relationships between eosinophils and neutrophils within and across airway compartments, with the exception of sputum neutrophil percentage.

Serum periostin and exhaled nitric oxide fraction (FeNO) are positively correlated with sputum and biopsy eosinophils in BOBCAT [3]. Both serum periostin and FeNO trend towards a positive correlation with biopsy neutrophils (rS=0.25, p=0.06 for periostin; rS=0.23, p=0.08 for FeNO), and exhibit significantly negative correlations with sputum neutrophils (rS= -0.31 for periostin, rS= -0.35 for FeNO; p<0.05 for each). None of the airway measures, nor blood biomarkers, exhibited significant correlations with lung function as assessed by FEV1 or asthma control as assessed by the ACQ (not shown).

Significantly elevated airway neutrophils are not typically observed in mild–moderate asthma patients not taking ICS or on low-dose ICS, but are often seen in severe asthma patients on high-dose steroids [7, 8], suggesting that chronic ICS treatment is related to elevated airway neutrophils. Our observations add to these findings by showing that, in patients with moderate–severe asthma, mucosal neutrophils are particularly elevated in subjects with tissue eosinophilia despite ICS treatment, and this relationship scales continuously.

Although eosinophil and neutrophil percentages in sputum are measured on a continuous scale, a desire to classify asthma into discrete subsets has yielded “cut-offs” for eosinophilia around 2–3%, whereas cut-offs for neutrophilia range from 40% to >60% [1, 2, 7, 9, 10]. This is because eosinophils are typically absent in nonasthmatic subjects, while a substantial proportion of sputum cells are neutrophils even in healthy subjects [9]. As a considerable fraction of sputum is composed of neutrophils, an increase in the proportion of another cell subset may come at the expense of neutrophil percentage, setting up a propensity for inherently negative correlations between proportions of the two cell types. While changes in the relative proportion of a minor component of the cellular content of a sample (e.g. sputum eosinophils) may be informative, caution must be exercised in interpreting the relevance of changes in the relative proportion of a component representing the majority or significant plurality of the cellular content of a sample (e.g. sputum neutrophils). Consistent with these considerations, sputum eosinophils exhibited substantial proportional variability, but remained a minor component of sputum cells and correlated with tissue and BAL eosinophils, serum periostin, blood eosinophils and FeNO [3]. Sputum neutrophils exhibited less proportional variability in this study and largely appeared to vary as a negative function of sputum eosinophil percentage (fig. 1).

The weakness of the positive correlations observed between eosinophils across sputum, biopsies and BAL may be due to several factors, including: 1) the three compartments sample different regions of the airways; 2) factors mediating transmigration of granulocytes through bronchial mucosal tissue into the airway lumen are poorly understood; 3) the techniques for enumerating and reporting granulocytes in each compartment vary; and 4) each assessment in this study is cross-sectional, with sputum sampling taking place close to, but not contemporaneous with bronchoscopy. Biomarkers that integrate total inflammatory burden systemically may present a means of circumventing the variability across airway compartments. As previously reported for the BOBCAT cohort, patients with low eosinophil levels in both sputum and bronchial tissue had the lowest serum periostin levels, while subjects with elevated eosinophils in either one or the other compartment had intermediate periostin levels, and subjects with elevated eosinophils in both sputum and bronchial tissue had the highest periostin levels [3]. Therefore, sampling multiple airway compartments and/or systemic biomarkers may be a more sensitive means to ascertain whether a given asthma patient has eosinophilic airway inflammation that may be missed by sampling only one compartment.

BOBCAT represents a large, well-characterised cohort of moderate–severe asthma patients resistant to high-dose ICS with intensive airway sampling. The key findings from this study are as follows. 1) Sputum, biopsy and BAL eosinophils are imperfectly but positively correlated, suggesting that eosinophilia in each of those compartments may be informative in moderate–severe asthma. 2) While neutrophils are positively correlated with eosinophils in biopsies and BAL, they are negatively correlated with eosinophils in sputum. Whether this is a technical artefact or a biologically relevant finding is unclear, but given recent attention devoted to “neutrophilic” phenotypes in severe asthma, this should be investigated further, particularly in the context of interventional studies of ICS and new investigational asthma therapies. 3) Eosinophil and neutrophil levels relate to each other on a continuous scale, which suggests that defining discrete cut-offs for airway phenotypes should be undertaken with caution. Future studies should also examine the longitudinal variability of granulocytic infiltration, as well as the ability of these phenotypic variables to predict outcomes in interventional studies.

Acknowledgments

We wish to thank the patients and clinical personnel who participated in this study.

Footnotes

  • Support statement: This study was funded by Genentech, Inc.

  • Conflict of interest: Disclosures can be found alongside the online version of this article at www.erj.ersjournals.com

  • Received July 9, 2013.
  • Accepted October 7, 2013.
  • ©ERS 2014

References

  1. ↵
    1. Simpson JL,
    2. Scott R,
    3. Boyle MJ,
    4. et al
    . Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11: 54–61.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Hastie AT,
    2. Moore WC,
    3. Meyers DA,
    4. et al
    . Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol 2010; 125: 1028–1036.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Jia G,
    2. Erickson RW,
    3. Choy DF,
    4. et al
    . Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012; 130: 647–654.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Juniper EF,
    2. O’Byrne PM,
    3. Guyatt GH,
    4. et al
    . Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999; 14: 902–907.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Hauber HP,
    2. Gotfried M,
    3. Newman K,
    4. et al
    . Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol 2003; 112: 58–63.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Pin I,
    2. Gibson PG,
    3. Kolendowicz R,
    4. et al
    . Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25–29.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. McGrath KW,
    2. Icitovic N,
    3. Boushey HA,
    4. et al
    . A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012; 185: 612–619.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Wenzel SE,
    2. Schwartz LB,
    3. Langmack EL,
    4. et al
    . Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999; 160: 1001–1008.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Belda J,
    2. Leigh R,
    3. Parameswaran K,
    4. et al
    . Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med 2000; 161: 475–478.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Haldar P,
    2. Brightling CE,
    3. Hargadon B,
    4. et al
    . Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360: 973–984.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
View this article with LENS
Vol 43 Issue 2 Table of Contents
European Respiratory Journal: 43 (2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Disconnect between sputum neutrophils and other measures of airway inflammation in asthma
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Disconnect between sputum neutrophils and other measures of airway inflammation in asthma
Joseph R. Arron, David F. Choy, Michel Laviolette, Steven G. Kelsen, Ammar Hatab, Richard Leigh, Neil C. Thomson, Eugene R. Bleecker, Ron Olivenstein, Pedro C. Avila, Nizar N. Jarjour, Mario Castro, Gail M. Gauvreau, James T. Good, Joel N. Kline, Adel Mansur, Irvin Mayers, Liam G. Heaney, Qutayba Hamid, Jeffrey M. Harris
European Respiratory Journal Feb 2014, 43 (2) 627-629; DOI: 10.1183/09031936.00117013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Disconnect between sputum neutrophils and other measures of airway inflammation in asthma
Joseph R. Arron, David F. Choy, Michel Laviolette, Steven G. Kelsen, Ammar Hatab, Richard Leigh, Neil C. Thomson, Eugene R. Bleecker, Ron Olivenstein, Pedro C. Avila, Nizar N. Jarjour, Mario Castro, Gail M. Gauvreau, James T. Good, Joel N. Kline, Adel Mansur, Irvin Mayers, Liam G. Heaney, Qutayba Hamid, Jeffrey M. Harris
European Respiratory Journal Feb 2014, 43 (2) 627-629; DOI: 10.1183/09031936.00117013
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Asthma and allergy
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Association between immunosuppressants and outcomes of COVID-19
Show more Agora

Research letters

  • Impact of depression and anxiety on exacerbation risk in bronchiectasis
  • Respiratory management of drowning-associated ARF
  • Mitochondrial DNA as biomarker of survival in RA-ILD
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society